BioCorRx (BICX) Non-Current Deferred Tax Liability (2016 - 2024)
Historic Non-Current Deferred Tax Liability for BioCorRx (BICX) over the last 11 years, with Q4 2024 value amounting to $39349.0.
- BioCorRx's Non-Current Deferred Tax Liability fell 8032.08% to $39349.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $39349.0, marking a year-over-year decrease of 8032.08%. This contributed to the annual value of $39349.0 for FY2024, which is 8032.08% down from last year.
- As of Q4 2024, BioCorRx's Non-Current Deferred Tax Liability stood at $39349.0, which was down 8032.08% from $199952.0 recorded in Q4 2023.
- Over the past 5 years, BioCorRx's Non-Current Deferred Tax Liability peaked at $573541.0 during Q4 2020, and registered a low of $39349.0 during Q4 2024.
- For the 5-year period, BioCorRx's Non-Current Deferred Tax Liability averaged around $322912.2, with its median value being $361781.0 (2022).
- Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first skyrocketed by 17637.43% in 2020, then crashed by 8032.08% in 2024.
- Quarter analysis of 5 years shows BioCorRx's Non-Current Deferred Tax Liability stood at $573541.0 in 2020, then fell by 23.29% to $439938.0 in 2021, then fell by 17.77% to $361781.0 in 2022, then tumbled by 44.73% to $199952.0 in 2023, then plummeted by 80.32% to $39349.0 in 2024.
- Its Non-Current Deferred Tax Liability stands at $39349.0 for Q4 2024, versus $199952.0 for Q4 2023 and $361781.0 for Q4 2022.